chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Skin sensitivity/pain when skin was touched by clothing or pain when skin was cold; Skin sensitivity/pain when skin was touched by clothing or pain when skin was cold; Random intense pain that would come and go on foot, hand, arm, back, chest; Random intense pain that would come and go on foot, hand, arm, back, chest; Random intense pain that would come and go on foot, hand, arm, back, chest; Headache; disorientation; Stomach ache; This is a spontaneous report from a contactable other HCP (patient) reporting for herself. A 36-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: En6208), via an unspecified route of administration, administered in Left arm on 10Mar2021 16:30 at the age of 36-years-old as dose 2, single for covid-19 immunisation. The patient's medical history was not reported. The patient had no known allergies. There were no concomitant medications. The patient previously took first dose of historical vaccine, bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EL9266), via an unspecified route of administration, administered in Left arm on 17Feb2021 05:30 PM at the age of 36-years-old as single dose for covid-19 immunisation. The patient did not receive other vaccine in four weeks of vaccination. The patient did not receive other medications in two weeks of vaccination. The patient was not diagnosed with COVID-19 prior vaccination. The patient has not been tested for COVID-19 post vaccination. On 11Mar2021 at 06:30, the patient experienced Skin sensitivity/pain when skin was touched by clothing or pain when skin was cold. Random intense pain that would come and go on foot, hand, arm, back, chest; Headache, disorientation and Stomach ache. No treatment was received for adverse events. Adverse events resulted in none of the above. The outcome of events was recovering.  No follow up attempts are possible. No further information is expected.
This serious spontaneous case, initially received on 07-Mar-2018, was reported by other non-healthcare professional (patient) and concerns a female patient of unspecified age. On 30-Sep-2017, the patient was administered with FLUCELVAX QIV (dose: 0.5 mg (as reported), route of administration: intra muscular, anatomical location: left deltoid, batch number: 195210, expiry date: not reported). On 07-Mar-2018, after 5 months 8 days of vaccination, the patient was diagnosed with flu type B. At the time of this report, outcome of the event flu type B was not reported.
01.06.21 Fever of 100.3 with chills  for 12 to 36 hours.
Major swelling and moderate pain at site of injection, light sensitivity, chills, moderate flu-like symptoms. Took Ibuprofen as needed. 9/12/2016 - Body aches, weakness in left arm, headache, moderate light sensitivity. Took Ibuprofen, consulted with person at CDC for advice. 09/13/2016 - Moderate flu-like symptoms, all major joints hurting, large painful lymph nodes in neck and armpit near injection site, painful left breast, chills, loss of appetite, lethargy, took ibuprofen and slept. 9/14/2016 - Woke up with swollen face and eyes, severe migraine like headache, took migraine medicine, moderate stiff neck upon awakening, applied ICY-HOT patch, took ibuprofen and slept in upright position, woke up around 1pm unable to turn head, unable to lift left arm, severe pain in neck, shoulder, arm, left hand, jaw pain when speaking or chewing. Went to primary doctor, sent from office to emergency room without treatment. Arrived at E.R. about 4pm, immediately isolated for suspected meningitis, administered IV fluids and pain medicine, rigorous testing including blood culture, CT-scan, xray, and spinal tap. Admitted into Hospital for evaluation and consultation with CDC. Released from Hospital on 9/15/2016 about 4pm.
8/15/05 Pneumonia vaccine administered. Complaint of increased pain (severe pain 24-48 hours) seen in ER for pain medication. No bruising, swelling, redness, chills, or fever.
Shot given March 25, 2021.  Next day: March 26, 2021 - Cold-like symptoms nasal congestion, runny nose, tired. Following day: March 27, 2021 - Allergic reaction increased to itching palate, nasal passages, slight asthma, congestion, runny nose. Treatment: Self administered OTC allergy medication Zyrtec. One dose 10mg. Allergy symptoms subsided in two hours except nasal congestion.
Pt. stated 8 hrs. after shot it swelled and was red 3 in. in diameter 48 hrs. Later hurt all the way to elbow took Aspirin felt better then was itching for 4 days.
Headaches, daily, 2 weeks; This case was reported by a consumer via call center representative and described the occurrence of headache in a 52-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 14th October 2022, the patient received the 1st dose of Shingrix. In October 2022, less than 3 weeks after receiving Shingrix, the patient experienced headache. On an unknown date, the outcome of the headache was recovered/resolved.   It was unknown if the reporter considered the headache to be related to Shingrix.     Additional Information: Reporter's Comment: The patient self-reported this case. The patient received dose of Shingrix vaccine and since then he/she had been experiencing headaches almost daily. The patient stated headaches had lasted more than 2 weeks. The patient asked if this  was common or he/she should report this to doctor. Additional supportive information: The follow-up would not possible, as no contact, details were available.
This spontaneous report was received from a Medical Assistant referring to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with improperly stored doses of GARDASIL 9 (strength, dose, route of administretion, frequency) lot # M034780 with expiration date of 15-APR-2019, for prophylaxis. No adverse effects reported. Administered doses of vaccines experienced the temperature excursion of 47 to 77 degrees Fahrenheit for 32 hours. Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1707USA008774: US-009507513-1707USA006516:
TINGLING OF THE LOWER EXTREMITIES; WEAKNESS FELT ALL OVER THE BODY; BODY/MUSCLE ACHES; FEVER; TIREDNESS FELT ALL OVER THE BODY; This spontaneous report received from a consumer concerned a 48 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: non-alcohol user, and non-smoker, and other pre-existing medical conditions included: The patient had no medical history. The patient had no known allergies. The patient had no history of drug abuse or illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, and batch number: 201A21A expiry: UNKNOWN) dose was not reported, administered on 18-AUG-2021 for prophylactic vaccination. No concomitant medications were reported. On 18-AUG-2021, the patient experienced tingling of the lower extremities. On 18-AUG-2021, the patient experienced weakness felt all over the body. On 18-AUG-2021, the patient experienced body/muscle aches. On 18-AUG-2021, the patient experienced fever. On 18-AUG-2021, the patient experienced tiredness felt all over the body. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever, and had not recovered from weakness felt all over the body, body/muscle aches, tingling of the lower extremities, and tiredness felt all over the body. This report was non-serious. This case, from the same reporter is linked to 20210938412.
16 yo female came into our injection site today 05/05/21 to receive her first pfizer vaccine. She was accompanied by her father. Pt received vaccine IM to her left deltoid. Pt completed vaccine at 2:55pm at which she sat down for her 15 minute observation period. As soon as she sat down she called over the staff that administered the vaccine. She explained to her that she felt nausea and was breathing heavily. I then walked over to them and the attendee was very pale and breathing heavily. By that time I had RN getting attendees history from her father, She has no history of allergic reactions, not taking any medications and no current illness. She is "slightly asthmatic" but is not taking any rx.  RN was helping me by putting cold pack behind attendees neck. Pt then proceeded to explain that she felt nauseas and starting dry heaving. RN then brought over trash can and attendee started to vomit. I then started to proceed and take her vitals. first set of vitals were taken at 2:58pm BP: 90/60 HR: 132 RR: 24 O2: 100%. Attendee at this point was diaphoretic, pale, breathing heavily and vomiting. We continued to monitor attendee in which she started to feel better by 3:08 pm. She was no longer pale, diaphoretic or vomitting and was breathing normally. We provided attendee with water and continued to monitor her. Now that pt was calm, I was able to ask her some questions. She stated that she had a smoothie and an avocado toast about an hour prior to vaccine. She explained to me that she does have a phobia to needles and was feeling very anxious prior to appointment. I then repeated her vitals at 3:16pm BP: 98/60 HR:89 RR: 20 O2: 99%.  I had attendee stand up off chair and walk at 3:22pm. She felt fine and did not feel dizzy at all. No signs of distress noted. She was then discharged and walked out with her dad at 3:25pm.
Syncope lasted about 5-10 seconds after HPV9 and varicella vaccination. Patient fainted momentary, I held her up in the chair and kept her head aligned. Patient regained consciousness a few seconds later. She wanted to lay down. I helped her to the floor since the bed was a few feet away and pt wasn't stable on her feet yet. She mentioned "passing out" before during a blood draw and other similar circumstances. She also hadn't had any breakfast I gave her a bar/granola and apple juice. Patient stayed in clinic for 10-15 min and said she was ready to leave and felt much better, she mentioned her arm felt heavy right after HPV9 vaccination. I told the pt she should come back another day for Hep A and Menveo. But after a discussion about vaccination and the A.E she had just experienced, patient decided to go ahead and received the remaining (Hep A and Menveo). Patient stay in bed after receiving those vaccine for another 5-10 min to make sure no A.E would occur. Patient reported feeling good. Patient left at around 1050 am. No other S/S reported by pt or observed.
Baby got vaccine 3 days ago and has been screaming for 3 days at the top of her lungs. The screaming has gotten worse and worse.
This case was reported by a consumer (patient's mother) and described the occurrence of septic shock in a 48-year-old female patient who was vaccinated with Influenza vaccine (unspecified, manufacturer unspecified). A physician or other health care professional has not verified this report. Concurrent medical conditions included seizure. Concurrent medications included Gabapentin and Herbal medication. Co-suspect medication included LAMICTAL. In early 2012, the patient started Lamotrigine (oral) at 100 mg twice per day. In 2012, the patient initially experienced some numbness and tingling in her fingers (numbness in finger and tingling in finger) that made her fingers feel funny. She then was doing okay on Lamotrigine until she started having some light seizures over the last 6 months [2013]. As a result, the physician had just increased her dosase from 2 pills a day to 3 a day but the mother of the patient was not sure if she had actually started the increased dosage. In October 2013 the patient received a dose of Influenza vaccine unspecified (unknown). On the evening of 30 October 2013 the patient collapsed and lost consciousness. The patient never regained consciousness. She was taken to the hospital right away. The patient was hospitalised and it was discovered that the patient was hemorrhaging. She did not have any platelets in her blood (low platelet value) and when she was given platelets, her blood just was not clotting. She had a slight infection in her bowel, which cleared up within one day with antibiotics. The patient was also retaining fluid and was all swelled up and puffy. The patient was put on life support because she was not breathing properly. The patient's kidneys failed on 01 November 2013 and on the 02 November 2013 her brain failed. She was therefore taken off life support on 02 November 2013 and died the same day. The death certificate listed septic shock as the cause of death. The patient's mother reported that the doctors did not know what caused the septic shock but did not think it was medication-related. The patient had received the Influenza vaccine unspecified at work and within 2-3 weeks of the events leading to her death. According to the mother, the Influenza vaccine unspecified "may have triggered all of it." The patient had mentioned after receiving the vaccine that she "felt terrible/awfully bad afterwards" (onset less than 2-3 weeks after vaccination). At the time of reporting, the events were fatal. The patient died on 2 November 2013 from septic shock. It is unknown whether an autopsy was performed.
Caller stated @ 10:15 am and about 5pm that afternoon nausea, itching and welts on the face and burning the ears. Caller took 50mg Benadryl. Once at hospital she received Decadron injection 4mg.  Caller slept for two hours and symptoms had dissipated.
5x2cm oval red, raised area on posterior aspect of left upper arm. denies pain, reports slight itching. oral or topical Benadryl advised per MD and monitor site.
Developing flushing of face within 15 minutes of vaccination, upon getting home, noted full body rash - itchy bumps. Headache and lightheaded with a slight little cough and able to taste something in mouth immediate. then one week later, 1/18/21 developed stabbing chest pain, medivac'ed 1/19/ 21 to tertiary facility hospital. had 2 stents placed on 1/20/21.  Received second dose of Moderna on 2/09/21, again having flushing, headache, taste, smell of medicine, rash, less severe than first dose. Took a nap following. Hurt all over all night 2/10/21. 2/11/21 felt somewhat better. one week later, again experienced shooting chest pain on 2/16/21 (pain 'down my breast bone'). Has not followed up with medical care. Has been 'living with it' due to expense of Medivac. Finally does have a follow up appointment with Dr. on June 7th.
This spontaneous repor0t as received from a pharmacist refers to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant medications were not reported. On 27-JUN-2016, the patient was inadvertently vaccinated intramuscularly in the left arm with an unknown dose of PNEUMOVAX23, which was expired (lot # K010465, expiry date 23-MAR-2016). No adverse effect was reported. Additional information has been requested.
BLOOD CLOT IN BRAIN LED TO A STROKE; This spontaneous potential legal case report received from a patient via social media through a company representative concerned a 38 year old patient of an unspecified sex, race and ethnic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported, expiry: unknown) dose, start therapy date were not reported, 1 total for prophylactic vaccination. Age at time of vaccination 4 decade. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced blood clot in brain that led to a stroke. Reporter stated that "Looking for someone to help me with a case against, vaccine giving me a blood clot in my brain that led to a stroke at the age of 38". The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the blood clot in brain led to a stroke was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20220547672-covid-19 vaccine ad26.cov2.s-Blood clot in brain led to a stroke. The event(s) has a unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable.
Six days after, I started being  awakened by the pain of my lips swelling to 3xs their size, tongue slightly swollen and throat possibly.  I took a Benedryl or Claritin and Advil.  Eight  hours after the 1st vaccine, I experienced severe aches and pain, fatigue lasting almost 72hrs. Even the joints of fingers aches but the pain in my lymph node in my left armpit felt like someone hit me with a baseball bat (injection was in left arm).
This case was reported by a physician via a sales representative and described the occurrence of swelling of arm following injection in a subject aged between 0 and 9 years old ("kindergarten age") of unspecified gender who was vaccinated with Infanrix (GlaxoSmithKline) for prophylaxis. Concurrent vaccination included live attenuated oral poliomyelitis vaccine (manufacturer unspecified) given on the same date as Infanrix. On an unspecified date the subject received unspecified dose of Infanrix (unknown, unknown arm). At an unspecified time after vaccination with Infanrix, the subject experienced swelling of the arm in which the injection was administered. The physician noted that the affected arm was three centimeters larger than the subject's other arm, and that the arm swelling extended past the elbow. The physician questioned whether there was a "problem with this lot of Infanrix" due to a similar reaction in a second patient (see GSK reference number A0670231A). Medical attention was required at a doctor's office. At the time of reporting the outcome of the event was unspecified. The physician considered the event was possibly related to vaccination Infanrix.
Pfizer vaccine was administered outside of source - reported by patient- ? NO LOT NUMBER WERE SUPPLIED ----------------------------------------------------------------------------------------------------------------- I21.4 ACUTE NON ST ELEVATION MI 8/21/2021 RECTAL CANCER I26.99 PULMONARY EMBOLISM, UNSPECIFIED. 6/11/2021 RECTAL CANCER I21.4 ACUTE NON ST ELEVATION MI 8/21/2021 HTN (HYPERTENSION) I26.99 PULMONARY EMBOLISM, UNSPECIFIED. 6/11/2021 HTN (HYPERTENSION) I21.4 ACUTE NON ST ELEVATION MI 8/21/2021 NAUSEA AND VOMITING I26.99 PULMONARY EMBOLISM, UNSPECIFIED. 6/11/2021 NAUSEA AND VOMITING I21.4 ACUTE NON ST ELEVATION MI 8/21/2021 HTN (HYPERTENSION) I26.99 PULMONARY EMBOLISM, UNSPECIFIED. 6/11/2021 HTN (HYPERTENSION) I21.4 ACUTE NON ST ELEVATION MI 8/21/2021 CANCER METASTATIC TO UNSPECIFIED LN I26.99 PULMONARY EMBOLISM, UNSPECIFIED. 6/11/2021 CANCER METASTATIC TO UNSPECIFIED LN
Initial solicited case was received from the investigator participating in a trial on 25 November 2014. A 24-year-old male subject, with no reported past medical history, had received the following vaccines on 15 July 2014: an injection of ACAM2000 (lot number, route and site of administration not reported), TYPHIM VI (lot number, route and site of administration not reported), and Anthrax vaccine (manufacturer, lot number, route and site of administration not reported). On 25 July 2014, the subject was diagnosed with unspecified chest pain. Abnormal results were found with ECG and echocardiogram performed on 25 July 2014. MRA (brain, spinal cord, heart) and lumbar puncture were not performed and Troponin I levels were not available. The subject's outcome was not reported. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Documents held by senders: none.
Chills(lasted appx 6 hours), low grade fever(highest was 100.7), fever lasted appx 18 hrs, headache, slight body aches,
pt recv vax & exp local rxn, flu like sx;immed area of redness, itching then inc redness & swelling of upper lt arm in red (illegible), lasted 3-4 days;
I became nauseous, light headed then fainted.  Had mild fever.  Recovered after reclining.
Shot #3 at pharmacy 12/22/2021- Patient reported feeling very unwell 12/25/2021 around 8 am complaining of " feels like I'm having a heart attack". Fever of 101.1 around 4 pm same day. Requested to go to ER 12/26/21 around 12 am due to terrible chest pain. He is still in ER at Medical Clinic. DX is pericarditis. No prior history of cardiac events. Moderate malaise during 12/21 to 12/24. Being treated currently with heparin, toradol, nitroglycerin, K+.
Pt evaluated at approximately 16:50 hrs. Noted Itchy throat, red raised rashes of anterior neck, red flushed appearing skin of upper chest, red raised rashes of Lt distal arm and palm of hand and Rt palm of hand.  Also noted fatigue.  Pt was given Diphenhydramine 25mg capsule, 2 capsules PO once at 16:55 hrs. Monitored in clinic for 35 minutes post Diphenhydramine administration. Rash of neck and upper chest and itchy throat subsided and resolved. Rash of Lt distal arm and palm of hand remained present but not any different in size or color. Rt palm rash resolved.
One week after MMR, developed joint pains; back, neck, hips & elbows.
reported eye vision changes, flashes of light, and a headache. Was treated in the emergency room.
Fever of 101.2, Bad headache, Really sore left arm, nauseous and  Chest pains
I started with fatigue and mild congestion.  Then, I had a headache and serve congestive.  On Jan. 23th, I tested positive for COVID-19 on a home test.  Then, I tested positive of Jan. 24th on a PCR test.  I had mostly cough, congestion, and fatigue that lasted for about a week.  The cough took about a month to go away.
When I has my first shot of Anthrax three days later I developed a lump like a birth mark in my left arm over the years I have three more on my left leg and I am suffering from constant abdominal pain and frequent muscle cramps.
COVID-19 confirmed by positive COVID-19 test; COVID-19 confirmed by positive COVID-19 test; This is a spontaneous report from a contactable consumer (patient). A 60-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) dose 1 on 13Apr2021 08:00 (Lot Number: Ew0151) at 60-year-old as 1ST DOSE, SINGLE for covid-19 immunisation. Facility type vaccine was Pharmacy or Drug Store. Medical history included Known allergies: Sulfur drug, Avocado. There were no concomitant medications.  No other vaccine in four weeks. No Other mediation in two weeks. No Covid prior vaccination. The patient developed covid on 31May2021 with outcome of recovering.  The event resulted in Doctor or other healthcare professional office/clinic visit. No treatment received. Covid test post vaccination included Nasal swab (Saliva) on 01Jun2021 with Positive result.
This spontaneous report was received from a pharmacist refers to a female patient of unknown age. Concurrent conditions, medical history and allergies were not reported. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX, (dose, frequency, route, anatomical location and lot number were not reported). Other suspect and concomitant therapies were not reported. On an unknown date, the patient developed a rash at her injection site and 8 days later, the site was still red. No further information was provided. The outcome of rash and the site was still red was reported as recovering/resolving. Additional information is not expected. The pharmacist declined to provide any information.